Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan...
Currently, cannabinoid substances are prohibited with the exception of CBD.
CBD Science has announced the launch of a funding raise to help advance cannabis-based treatments for cancer pain.
Kanabo's VapePod can now be purchased on Handpicked CBD.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
The company says the appointment will be of great value as it builds its investment portfolio.
The NACA has signed three groundbreaking agreements which support the use of tribal farmland for cannabis cultivation.
The campaign could lead to a popular referendum on the decriminalisation of cannabis in spring 2022.
Shannett Thompson, partner at Kingsley Napley LLP, explores the regulations around cannabis and investment in the UK.
Grow and Sanoid aim to supply high quality cannabis products at an affordable price point for patients.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in treating COVID-19 patients.
Apeiron Investment Group is now the largest shareholder of European cannabis company SynBiotic.
The certification has been launched for the needs of insurance producers, agents, risk managers, and others in cannabis business.